Saturna Capital’s Medtronic MDT Stock Holding History

Saturna Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-45	Closed	-$3K	–	255
2015 Q4	$3K	Buy	+45	New	+$3.39K	﹤0.01%	358

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Saturna Capital's MDT Position: Q1 2016 in Review

Saturna Capital sold out of Medtronic (MDT) in Q1 2016, closing a stake of 45 shares — an estimated $3K sold.

Saturna Capital first reported a position in MDT in Q4 2015 and held it in 1 quarter. The position peaked at $3K in Q4 2015. 1,240 funds tracked by Wall St. Rank hold MDT as of Q1 2016.

Saturna Capital reported no remaining Medtronic position as of Q1 2016 after selling out during the quarter.
Saturna Capital sold 45 Medtronic shares in Q1 2016, an estimated $3K.
Saturna Capital first reported a position in Medtronic in Q4 2015 and held it in 1 quarter.
Saturna Capital's Medtronic position peaked at $3K in Q4 2015.
1,240 funds tracked by Wall St. Rank held Medtronic as of Q1 2016.

Based on Saturna Capital's 13F filing for Q1 2016, filed 13 May 2016.